These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice. Rowell J; Lo CY; Price GE; Misplon JA; Crim RL; Jayanti P; Beeler J; Epstein SL PLoS One; 2019; 14(4):e0215321. PubMed ID: 30986224 [TBL] [Abstract][Full Text] [Related]
30. An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses. do Nascimento GM; Bugybayeva D; Patil V; Schrock J; Yadagiri G; Renukaradhya GJ; Diel DG Viruses; 2023 Apr; 15(4):. PubMed ID: 37112974 [TBL] [Abstract][Full Text] [Related]
31. Protective Efficacy of an Orf Virus-Vector Encoding the Hemagglutinin and the Nucleoprotein of Influenza A Virus in Swine. Joshi LR; Knudsen D; Piñeyro P; Dhakal S; Renukaradhya GJ; Diel DG Front Immunol; 2021; 12():747574. PubMed ID: 34804030 [TBL] [Abstract][Full Text] [Related]
32. Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling. Wang Q; Pan W; Wang S; Pan C; Ning H; Huang S; Chiu SH; Chen JL J Virol; 2021 Feb; 95(6):. PubMed ID: 33361428 [TBL] [Abstract][Full Text] [Related]
33. Early vaccine-mediated strain-specific cytokine imbalance induces mild immunopathology during influenza infection. Bull MB; Ma FN; Perera LP; Poon LL; Valkenburg SA Immunol Cell Biol; 2023 Jul; 101(6):514-524. PubMed ID: 36401824 [TBL] [Abstract][Full Text] [Related]
34. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells. Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970 [TBL] [Abstract][Full Text] [Related]
35. Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression. Wang S; Chi X; Wei H; Chen Y; Chen Z; Huang S; Chen JL J Virol; 2014 Aug; 88(15):8375-85. PubMed ID: 24829357 [TBL] [Abstract][Full Text] [Related]
36. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies. Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855 [TBL] [Abstract][Full Text] [Related]
37. Influenza Virus: A Master Tactician in Innate Immune Evasion and Novel Therapeutic Interventions. Hsu AC Front Immunol; 2018; 9():743. PubMed ID: 29755452 [TBL] [Abstract][Full Text] [Related]
38. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
40. Influenza A Virus Studies in a Mouse Model of Infection. Rodriguez L; Nogales A; Martínez-Sobrido L J Vis Exp; 2017 Sep; (127):. PubMed ID: 28930978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]